SnapCyte Solutions Invited to France to Advance Research Collaborations and EU Strengthen Partnerships
Recognized for Innovation, SnapCyte Strengthens European Collaborations in Cancer Research and Biotechnology.
Vancouver, BC | Dec 15, 2024 | SnapCyte Solutions Inc., a leader in cell monitoring and analytics technology and services, was invited to France as part of the Mourou/Strickland Canada Mobility Program, funded by the French Embassy in Canada. Recognized for its innovative expertise and proven technology, SnapCyte engaged with leading French institutions, researchers, and businesses to advance collaborative research, build on existing EU partnerships, and explore new opportunities in cancer research, life sciences, and biotechnology.
During the visit, SnapCyte met with scientists at the renowned Institut Gustave Roussy to review progress on an ongoing trial and identify further opportunities for joint research projects. A seminar hosted at the institute allowed SnapCyte to showcase its capabilities to the broader scientific community, strengthening its reputation as a key player in cell monitoring and analytics.
SnapCyte also engaged with companies in artificial intelligence, machine learning, and biotechnology, fostering discussions on synergies that could enhance both technological capabilities and research outcomes. Additionally, SnapCyte explored innovative applications for its technology in agricultural biotechnology, particularly in cell analytics for spirulina farming. The trip included collaboration with the Canadian Trade Commissioner for Life Sciences in Paris to establish a robust network of scientific and commercial partners, further solidifying SnapCyte’s presence in Europe. Leveraging its existing relationships with customers in the UK and EU, SnapCyte gathered valuable market insights to drive research collaborations and long-term partnerships across France’s dynamic biotech ecosystem.
“This invitation was a tremendous opportunity for SnapCyte to share our technology and expertise with France’s leading researchers and businesses,” said Nader Al Nakouzi, CSO at SnapCyte. “We’re building on our strong foundation in the UK and EU, and this trip has opened
exciting pathways for deeper collaboration in cancer research, life sciences, and agricultural
biotechnology.” SnapCyte’s highly productive visit reinforces its role as an innovative leader in the global biotech community and highlights its commitment to advancing scientific research through strategic collaborations.
About SnapCyte™
SnapCyte™ is a cutting-edge platform and services company specializing in automated cell monitoring and analytics technologies, serving researchers and the cell imaging industry globally. The firm leverages AI technology to simplify and speed up workflows for cell proliferation, cell counting, and other assays, offering accurate, reproducible results in less time. Contact: contact@snapcyte.com.
